Hospital Acquired Infections Therapeutic Market (By Drug Class: Antibacterial Drugs, Antiviral Drugs, Antifungal Drugs; By Infection Type: Urinary Tract Infections, Ventilator-associated Pneumonia, Surgical Site Infections, Bloodstream Infections, Other Hospital Infections) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Published Date : Feb 2021 | No. of Pages : 250 Pages | Category : Healthcare


Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Hospital Acquired Infections Therapeutic Market, By Drug Class

7.1.  Hospital Acquired Infections Therapeutic Market, By Drug Class Type, 2020-2030

7.1.1.    Antibacterial Drugs

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Antiviral Drugs

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Antifungal Drugs

7.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Hospital Acquired Infections Therapeutic Market, By Application

8.1.  Hospital Acquired Infections Therapeutic Market, by Application, 2020-2030

8.1.1.    Urinary Tract Infections

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Ventilator-associated Pneumonia

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Surgical Site Infections

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    Bloodstream Infections

8.1.4.1.        Market Revenue and Forecast (2016-2030)

8.1.5.    Other Hospital Infections

8.1.5.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Hospital Acquired Infections Therapeutic Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, By Drug Class (2016-2030)

9.1.2.    Market Revenue and Forecast, by Application (2016-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.1.3.2.        Market Revenue and Forecast, by Application (2016-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.1.4.2.        Market Revenue and Forecast, by Application (2016-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, By Drug Class (2016-2030)

9.2.2.    Market Revenue and Forecast, by Application (2016-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.2.3.2.        Market Revenue and Forecast, by Application (2016-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.2.4.2.        Market Revenue and Forecast, by Application (2016-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.2.5.2.        Market Revenue and Forecast, by Application (2016-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.2.6.2.        Market Revenue and Forecast, by Application (2016-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, By Drug Class (2016-2030)

9.3.2.    Market Revenue and Forecast, by Application (2016-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.3.3.2.        Market Revenue and Forecast, by Application (2016-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.3.4.2.        Market Revenue and Forecast, by Application (2016-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.3.5.2.        Market Revenue and Forecast, by Application (2016-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.3.6.2.        Market Revenue and Forecast, by Application (2016-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, By Drug Class (2016-2030)

9.4.2.    Market Revenue and Forecast, by Application (2016-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.4.3.2.        Market Revenue and Forecast, by Application (2016-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.4.4.2.        Market Revenue and Forecast, by Application (2016-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.4.5.2.        Market Revenue and Forecast, by Application (2016-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.4.6.2.        Market Revenue and Forecast, by Application (2016-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, By Drug Class (2016-2030)

9.5.2.    Market Revenue and Forecast, by Application (2016-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.5.3.2.        Market Revenue and Forecast, by Application (2016-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, By Drug Class (2016-2030)

9.5.4.2.        Market Revenue and Forecast, by Application (2016-2030)

Chapter 10.  Company Profiles

10.1.              Merck & Co., Inc.

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Pfizer Inc.

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Bayer AG

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              GlaxoSmithKline Plc.

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Daiichi Sankyo Company, Limited

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              AbbVie Inc.

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Abbott Laboratories

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              F. Hoffmann-La Roche Ltd

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Allergan Plc.

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms

Featured Research Reports

  • Featured Research Reports

    Cancer Supportive Care Drugs Market (By Therapeutic Class: G-CSFs, Anti-emetics, ESAs, Bisphosphonates, Opioids, NSAIDs & Others)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    eHealth Devices Market( By Type: Blood Pressure Meters, Fever Meters, Glucose Meters, Care Phone/Social Alarms)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Tracheostomy Products Market (By Demographics: Adults, Paediatrics/Neonatal; By Type: Tracheostomy Tubes, Ventilation Accessories ; By End Use: Hospitals & Surgery Centers, Ambulatory Care Centers, Home Care Settings, Others; By Technique) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Smart Blood Pressure Monitoring Devices Market (By Type: Upper Arm Blood Pressure Monitor, Wrist Blood Pressure Monitor Finger Blood Pressure Monitor; By Technology: Wi-Fi Based/4G, Bluetooth Based)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Laparoscopic Electrodes Market (By Application: Bariatric, General Surgeries; By Product: Monopolar, Bipolar Electrodes; By End User: Hospital, Ambulatory)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...